Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER_GOV × vactosertib × Clear all

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

apatinib 22 Cisplatin 19 Capecitabine 17 Irinotecan 15 Radiotherapy 12 camrelizumab 11 Paclitaxel 11 Drug Therapy 11 Cyclophosphamide 11 S 1 (combination) 10 Oxaliplatin 10 fludarabine 9 Carboplatin 9 Blood Specimen Collection 9 Bevacizumab 9 Docetaxel 8 Radiation 7 Nivolumab 7 Gemcitabine 7 Fluorouracil 7 Erlotinib Hydrochloride 7 tislelizumab 6 Surgical Procedures, Operative 6 Neoadjuvant Therapy 6 toripalimab 5 XELOX 5 Propranolol 5 Exercise 5 Doxorubicin 5 Chemoradiotherapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04893252 2022-11-30

Vactosertib and Durvalumab in Gastric Cancer

National Cancer Center, Korea

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡